A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma
type: MedicalStudy
description: A Phase II Trial of Bortezomib, Doxorubicin and Dexamethasone (PAD) Induction Therapy in Patients With Untreated Multiple Myeloma (MM), Stratified for Markers of Bortezomib Resistance
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2009-01
end date: 2011-11
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00872521
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Janssen-Cilag Pty Ltd
study subject: Multiple Myeloma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Multiple Myeloma

AI Analytics
type: Organization